The Technical Analyst
Select Language :
Enzo Biochem Inc [ENZ]

Exchange: NYSE Sector: Healthcare Industry: Diagnostics & Research

Enzo Biochem Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Enzo Biochem Inc is listed at the  Exchange

-0.85% $1.170

America/New_York / 12 apr 2024 @ 16:00


Enzo Biochem Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 59.93 mill
EPS: -0.470
P/E: -2.49
Earnings Date: Jun 11, 2024
SharesOutstanding: 51.23 mill
Avg Daily Volume: 0.103 mill
RATING 2024-04-12
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.49 | sector: PE 15.43
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -2.49 | industry: PE 109.92
DISCOUNTED CASH FLOW VALUE
$-0.953
(-181.45%) $-2.12
Date: 2024-04-13
Expected Trading Range (DAY)

$ 1.111 - 1.229

( +/- 5.04%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-23 Cannon Kara Buy 150 000 Common Stock
2024-02-21 Cannon Kara Buy 10 640 Common Stock
2024-02-21 Cannon Kara Sell 5 823 Common Stock
2024-02-23 Eckert Patricia Buy 75 000 Stock Option (to acquire shares of Common Stock)
2024-01-31 Pully Steven J Buy 79 365 Common Stock
INSIDER POWER
88.74
Last 85 transactions
Buy: 4 325 861 | Sell: 177 248

Forecast: 16:00 - $1.180

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.180
Forecast 2: 16:00 - $1.180
Forecast 3: 16:00 - $1.180
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.170 (-0.85% )
Volume 0.103 mill
Avg. Vol. 0.103 mill
% of Avg. Vol 100.18 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Enzo Biochem Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Enzo Biochem Inc

RSI

Intraday RSI14 chart for Enzo Biochem Inc

Last 10 Buy & Sell Signals For ENZ

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Enzo Biochem Inc

ENZ

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing ‘STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
PAXGUSDApr 13 - 18:252 414.33
CTXUSDApr 13 - 18:143.62
PROUSDApr 13 - 17:35$3.20
SBDUSDApr 13 - 17:31$3.74
CFXUSDApr 13 - 16:08$0.224
BAKEUSDApr 13 - 15:54$0.247
CREAMUSDApr 13 - 15:5440.99
FUMOUSDApr 13 - 17:147 507.86
PROPCUSDApr 13 - 17:083.45
ADFUSDApr 13 - 17:090.777

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.